EDX Medical Group

EDX Medical Group EBITDA per Employee

The EBITDA per Employee of EDX Medical Group (EDX.AQ) as of Nov 2, 2026 is -1.32 M GBP. In the previous year, EBITDA per Employee was -1.02 M GBP — a change of 29.39% (lower).

EBITDA per Employee

-1.32 MGBP

YoY

29.39%

Last updated:

EBITDA per Employee of EDX Medical Group is 2025 -1.32 M GBP. EBITDA per Employee of EDX Medical Group was 2024 -1.02 M GBP. It decreases by 29.39% lower compared to the previous year.

The EDX Medical Group EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2021
-3,733.33 GBP
Jan 1, 2022
-84,466.67 GBP
Jan 1, 2023
-860,133.33 GBP
Jan 1, 2024
-1.02 M GBP
Jan 1, 2025
-1.32 M GBP
The EDX Medical Group EBITDA per Employee history
YEAREBITDA per EmployeeYoY
-1.32 MGBP+29.39%
-1.02 MGBP+18.72%
-860,133.33GBP+918.31%
-84,466.67GBP+2,162.50%
-3,733.33GBP—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

EDX Medical Group Stock analysis

What does EDX Medical Group do? EDX Medical Group Plc generates revenue through the sale of digitally enabled diagnostic products and services to individuals and organizations. The company offers point-of-care, home, and workplace testing tools that allow personalized diagnosis according to international standards. Its disease surveillance solutions are sold to cross-border agencies and governments for identifying new disease variants with high transmission risks. The firm also partners with researchers and clinicians to commercialize their discoveries into marketable products. The primary buyers of EDX Medical Group's diagnostic tools include healthcare professionals, individuals seeking personal health monitoring, and government agencies responsible for public health surveillance. Cross-border agencies utilize the disease surveillance solutions to track rapidly spreading variants. Researchers and clinicians form strategic partnerships to develop and launch new diagnostic products through the company's platform. EDX Medical Group's product portfolio consists of diagnostic tests for point-of-care, home, and workplace use, alongside disease surveillance systems. The company's services focus on enabling personalized medical diagnosis and early detection of disease variants. Revenue streams are derived from direct sales of diagnostic tools, government contracts for surveillance systems, and partnership agreements with research institutions. EDX Medical Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EDX Medical Group stock

EBITDA per Employee of EDX Medical Group is -1.32 M GBP in 2025.

EBITDA per Employee of EDX Medical Group changed from -1.02 M GBP to -1.32 M GBP, representing a 29.39% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee EDX Medical Group since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's GBP is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's EDX Medical Group historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — EDX Medical Group

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — EDX Medical Group